MedTrace Logo

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)

NCT05265169 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 275

Last updated 2024-01-17

No results posted yet for this study

Summary

To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.

Conditions

  • Colorectal Liver Metastases

Interventions

DEVICE

Microwave ablation

Microwave ablation of colorectal liver metastases (CLM)

Sponsors & Collaborators

  • Society of Interventional Oncology

    lead OTHER

Principal Investigators

  • Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-13
Primary Completion
2027-11-11
Completion
2027-12-10
FDA Device
Yes

Countries

  • United States
  • Greece
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05265169 on ClinicalTrials.gov